Compounds > 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
Page last updated: 2024-09-04

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Leukemia P388

1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione has been researched along with Leukemia P388 in 1 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cholody, WM; Konopa, J; Martelli, S; Paradziej-Lukowicz, J1

Other Studies

1 other study(ies) available for 1-hydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione and Leukemia P388

ArticleYear
5-[(Aminoalkyl)amino]imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: Acridines; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Chemistry, Physical; HeLa Cells; Humans; Imidazoles; Leukemia P388; Mice; Molecular Structure; Structure-Activity Relationship

1990